Leyden Labs

About:

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Website: http://www.leydenlabs.com/

Twitter/X: LeydenLabs

Top Investors: Qiming Venture Partners, F-Prime Capital, Invus, Google Ventures, SoftBank Vision Fund

Description:

Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses. Its portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The Company’s energetic team of world-renown biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.

Total Funding Amount:

$258M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Amsterdam, Noord-Holland, The Netherlands

Founded Date:

2020-01-01

Contact Email:

info(AT)leydenlabs.com

Founders:

Dinko Valerio, Jaap Goudsmit, Koenraad Wiedhaup, Ronald Brus

Number of Employees:

51-100

Last Funding Date:

2024-09-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai